Durham Vaccine Manufacturing Facility Nestled among the tree in Treyburn Corporate Park, The modern, "green" facility is Merck's response to growing vaccine business. Construction on the site has been ongoing since 2004, with two expansions announced since the project began schduled for completion by 2012.
Dr. Maurice R. Hilleman -
During his 30 years at Merck, Dr. Hilleman developed vaccines for eight of the diseases for which vaccines are routinely recommended for children in the United States, including measles, mumps and rubella. One of the world's most noted vaccine researchers, Dr. Hilleman has been credited by his peers for helping to save more lives than any other scientist in the 20th century. In addition to vaccines that protect against measles, mumps and rubella, Dr. Hilleman played a leading role in the development of vaccines against hepatitis A, hepatitis B, meningitis, pneumonia and Haemophilus influenzae bacteria, and was the first to identify the "shift" and "drift" concepts of flu that are still used today in developing annual flu vaccines. In 1988 he received the National Medal of Science, the nation's highest scientific honor.